Cognitive Function in Duchenne Muscular Dystrophy Patients
Duchenne muscular dystrophy is a rare, progressive, X-linked recessive disorder, characterized by impaired synthesis of the protein dystrophin. Motor symptoms in boys typically emerge within the first year of life, followed by progressive cardiac ...
Viktorija Urbanovič +1 more
doaj +1 more source
Cardioprotective hormone relaxin‐2 showed relevant effects on rat skeletal muscle by altering proteins linked to muscle function, regeneration, differentiation, mitochondrial function, glucose metabolism, and structural integrity and organization. Specifically, relaxin‐2 reduced the expression of 95 proteins, increased 32, and elicited unique proteins ...
Xocas Vázquez‐Abuín +11 more
wiley +1 more source
Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber +4 more
wiley +1 more source
Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP
Skeletal muscle wasting results from numerous pathological conditions affecting both the musculoskeletal and nervous systems. A unifying feature of these pathologies is the upregulation of members of the E3 ubiquitin ligase family, resulting in increased
Avnika A. Ruparelia +12 more
doaj +1 more source
Computer task performance by subjects with Duchenne muscular dystrophy
Silvia Regina Pinheiro Malheiros,1 Talita Dias da Silva,2 Francis Meire Favero,2 Luiz Carlos de Abreu,1 Felipe Fregni,3 Denise Cardoso Ribeiro,4 Carlos Bandeira de Mello Monteiro1,4,5 1School of Medicine of ABC, Santo Andre, Brazil; 2Department of ...
Ribeiro DC +6 more
core
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Steve D Wilton, Sue FletcherCentre for Neuromuscular and Neurological Disorders, University of Western Australia, Crawley, Perth, WA, AustraliaAbstract: The identification of dystrophin and the causative role of mutations in this gene in Duchenne and ...
Steve D Wilton, Sue Fletcher
core
Severe fat embolism syndrome following minor trauma in a child with Duchenne muscular dystrophy: A case report. [PDF]
Montero-Yéboles R +5 more
europepmc +1 more source
Congenital Clubfoot as an Early Manifestation of Duchenne Muscular Dystrophy? [PDF]
Kenis V +4 more
europepmc +1 more source
Erratum: Microdystrophins partially rescue deficits of Duchenne muscular dystrophy iPSC-cardiomyocytes. [PDF]
Keegan AR +14 more
europepmc +1 more source
A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy. [PDF]
Chaudhary JH +4 more
europepmc +1 more source

